News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Judith D. Bebchuk

Articles by Judith D. Bebchuk

TPS 105 ALISertib in Combination With Endocrine Therapy in Patients With Hormone Receptor-Positive, HER2-Negative Recurrent or Metastatic Breast Cancer: the Phase 2 ALISCA-Breast1 Study

ByPooja Advani, MBBS, MD,Sofia Braga,Adam M. Brufsky, MD, PhD,Karthik V. Giridhar,Erica L. Mayer, MD, MPH,Kelly E. McCann,Ruth M. O’Regan,Cristina Saura,Seth A. Wander,Georg F. Bischof,Beth H. Lowenthal,Judith D. Bebchuk,Lisa D. Eli,Brian G. Barnett,Joyce A. O’Shaughnessy,Tufia C. Haddad

April 11th 2025

Latest Updated Articles

Trending on CancerNetwork

Withdrawal Planned for Second-Line Lurbinectedin in SCLC Indication

Clinical Implications of Earlier CAR-T Therapy in Relapsed/Refractory Multiple Myeloma

NCCN Guidelines: Navigating ctDNA MRD Testing in Evolving MIBC Paradigms

CARTITUDE-4 Supports Earlier CAR-T Use in Relapsed/Refractory Multiple Myeloma

Cevostamab Trial Validates FcRH5 as a Multiple Myeloma Target